PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
13.12%
Revenue growth of 13.12% while ON is flat. Bruce Berkowitz would check if a small edge can widen further.
16.17%
Gross profit growth of 16.17% while ON is zero. Bruce Berkowitz would see if minimal improvements could expand further.
10.22%
EBIT growth of 10.22% while ON is zero. Bruce Berkowitz would see if small gains can be scaled further.
12.17%
Operating income growth of 12.17% while ON is zero. Bruce Berkowitz would see if this modest edge can become significant.
13.43%
Net income growth of 13.43% while ON is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
8.33%
EPS growth of 8.33% while ON is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
8.70%
Diluted EPS growth of 8.70% while ON is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
2.53%
Share change of 2.53% while ON is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
1.38%
Diluted share change of 1.38% while ON is zero. Bruce Berkowitz might see a minor difference that could widen over time.
0.49%
Dividend growth of 0.49% while ON is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
83.58%
OCF growth of 83.58% while ON is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
152.78%
FCF growth of 152.78% while ON is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
12.26%
10Y CAGR of 12.26% while ON is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
-16.56%
Negative 5Y CAGR while ON stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
101.94%
3Y CAGR of 101.94% while ON is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
153.21%
OCF/share CAGR of 153.21% while ON is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
94.23%
OCF/share CAGR of 94.23% while ON is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
34.58%
3Y OCF/share CAGR of 34.58% while ON is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
882.41%
10Y net income/share CAGR of 882.41% while ON is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
108.68%
Net income/share CAGR of 108.68% while ON is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
1537.14%
3Y net income/share CAGR of 1537.14% while ON is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
188.07%
Equity/share CAGR of 188.07% while ON is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
162.02%
Equity/share CAGR of 162.02% while ON is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
99.34%
Equity/share CAGR of 99.34% while ON is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
10.49%
Dividend/share CAGR of 10.49% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
27.18%
Dividend/share CAGR of 27.18% while ON is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
-6.24%
Negative near-term dividend growth while ON invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-5.96%
Firm’s AR is declining while ON shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
18.73%
Inventory growth of 18.73% while ON is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
13.87%
Asset growth of 13.87% while ON is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
13.93%
BV/share growth of 13.93% while ON is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
-0.91%
We’re deleveraging while ON stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-3.71%
Our R&D shrinks while ON invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
28.49%
SG&A growth of 28.49% while ON is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.